You are here

  • Home
  • Archive
  • Volume 12, Issue 1
  • Experience of patients considering or using checkpoint inhibitors in cancer treatment: a systematic review of qualitative research

Article info

Article menu
Review
Experience of patients considering or using checkpoint inhibitors in cancer treatment: a systematic review of qualitative research

Authors

  • Raphael Yip Centre for Healthcare Resilience and Implementation (CHRIS), Macquarie University Faculty of Medicine and Health Sciences, Sydney, New South Wales, AustraliaMedicine, North Sydney Local Health District, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Gaston Arnolda Centre for Healthcare Resilience and Implementation (CHRIS), Macquarie University Faculty of Medicine and Health Sciences, Sydney, New South Wales, AustraliaCentre for Healthcare Resilience and Implementation (CHRIS), Australian Institute of Health Innovation, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Klay Lamprell Centre for Healthcare Resilience and Implementation (CHRIS), Macquarie University Faculty of Medicine and Health Sciences, Sydney, New South Wales, AustraliaCentre for Healthcare Resilience and Implementation (CHRIS), Australian Institute of Health Innovation, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Bróna Nic Giolla Easpaig Centre for Healthcare Resilience and Implementation (CHRIS), Macquarie University Faculty of Medicine and Health Sciences, Sydney, New South Wales, AustraliaCentre for Healthcare Resilience and Implementation (CHRIS), Australian Institute of Health Innovation, Sydney, New South Wales, AustraliaSchool of Nursing, Charles Darwin University Faculty of Health, Darwin, Northern Territory, Australia PubMed articlesGoogle scholar articles
  • Renuka Chittajallu Centre for Healthcare Resilience and Implementation (CHRIS), Macquarie University Faculty of Medicine and Health Sciences, Sydney, New South Wales, AustraliaCentre for Healthcare Resilience and Implementation (CHRIS), Australian Institute of Health Innovation, Sydney, New South Wales, AustraliaMedical Oncology, Riverina Cancer Care Centre, Wagga Wagga, New South Wales, AustraliaMedical Oncology, GenesisCare, Kingswood, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Geoff Delaney South-Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, AustraliaRadiation Oncology, Liverpool Hospital, Liverpool, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Ian Olver School of Psychology, The University of Adelaide Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia PubMed articlesGoogle scholar articles
  • Winston Liauw St George Cancer Centre, Saint George Hospital, Kogarah, New South Wales, AustraliaSt. George Hospital Clinical School, University of New South Wales, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Jeffrey Braithwaite Centre for Healthcare Resilience and Implementation (CHRIS), Macquarie University Faculty of Medicine and Health Sciences, Sydney, New South Wales, AustraliaCentre for Healthcare Resilience and Implementation (CHRIS), Australian Institute of Health Innovation, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles

Citation

Yip R, Arnolda G, Lamprell K, et al
Experience of patients considering or using checkpoint inhibitors in cancer treatment: a systematic review of qualitative research
Journal for ImmunoTherapy of Cancer 2024;12:e007555. doi: 10.1136/jitc-2023-007555
Online issue publication 
January 11, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.